A Controlled Study of Nortriptyline in Children and Adolescents with Attention Deficit Hyperactivity Disorder
Authors:
- 1 September 2000
- journal article
- research article
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 10 (3) , 193-204
Abstract
Objectives: To study the efficacy and tolerability of nortriptyline (NT) in the treatment of pediatric attention deficit hyperactivity disorder (ADHD). Methodology: Subjects were outpatient children and adolescents with ADHD ascertained from clinical referrals. Subjects were enrolled in a 6-week open study in which NT was titrated to 2 mg/kg/day as tolerated over 2 weeks. Using either a 30% reduction in the ADHD rating scale or a score of 1 or 2 on the Clinical Global Impression (CGI) scale for ADHD improvement, responders to treatment were then randomized into a 3-week, controlled discontinuation phase. During this phase, subjects either continued on their current dose of NT or were tapered to placebo under double-blind conditions. Subjects were monitored for symptoms of ADHD, oppositionality, anxiety, and depression. Results: Of the 35 subjects enrolled in the study, 32 completed the open phase and 23 completed the discontinuation phase. The mean dose of NT was 80 mg (1.8 mg/kg/day), resulting in a serum level of 81 ng/ml. At the conclusion of the open 6-week study, NT was related to a significant reduction in ADHD (p < 0.001) and oppositional symptoms (p < 0.001). At the conclusion of the discontinuation phase, the 12 subjects randomized to NT had significantly lower scores on the DSM-IV ADHD symptom checklist than those 11 subjects randomized to placebo (31 versus 21; t = 2.2; p < 0.04). No significant adverse events were observed, and children were noted to have weight gain during the trial. Conclusions: These data suggest that NT is effective in reducing symptoms not only of ADHD but also of oppositionality. This group of children and adolescents tolerated robust dosing of NT well, with few clinical or cardiovascular adverse events.Keywords
This publication has 13 references indexed in Scilit:
- A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity DisorderArchives of General Psychiatry, 1999
- Neuropsychological function in adults with attention-deficit hyperactivity disorderBiological Psychiatry, 1998
- Cardiovascular Effects of Therapeutic Doses of Tricyclic Antidepressants in Children and AdolescentsJournal of the American Academy of Child & Adolescent Psychiatry, 1996
- Some Conceptual and Statistical Issues in Analysis of Longitudinal Psychiatric DataArchives of General Psychiatry, 1993
- Sudden Death in Children Receiving Norpramin®: A Review of Three Reported Cases and CommentaryJournal of the American Academy of Child & Adolescent Psychiatry, 1991
- A Double-Blind Placebo Controlled Study of Desipramine in the Treatment of ADD: I. EfficacyJournal of the American Academy of Child & Adolescent Psychiatry, 1989
- Antidepressants in childhood attention deficit disorder and obsessive-compulsive disorderPsychosomatics, 1986
- A REVIEW OF STIMULANT DRUG RESEARCH WITH HYPERACTIVE CHILDRENJournal of Child Psychology and Psychiatry, 1977
- A Clinical Trial Design Avoiding Undue Placebo TreatmentThe Journal of Clinical Pharmacology, 1975
- One-year follow-up of hyperactive boys treated with imipramine or methylphenidateAmerican Journal of Psychiatry, 1975